Doxorubicin-enriched, ALDHbr mouse breast cancer stem cells are treatable to oncolytic herpes simplex virus type 1

Xiufen Zhuang; Wen Zhang; Yatong Chen; Xiangping Han; Jie Li; Yu Zhang; Youhui Zhang; Shuren Zhang; Binlei Liu

doi:10.1186/1471-2407-12-549

Download references

Doxorubicin-enriched, ALDH^br mouse breast cancer stem cells are treatable to oncolytic herpes simplex virus type 1

Xiufen Zhuang, Wen Zhang, Yatong Chen, Xiangping Han, Jie Li, Yu Zhang, Youhui Zhang, Shuren Zhang^* and Binlei Liu^*

* Corresponding authors: Shuren Zhang biotherapy@caca.sina.net - Binlei Liu liubl1@yahoo.com

BMC Cancer 2012, 12:549 doi:10.1186/1471-2407-12-549

Include	Article citation and all cited references Cited references only Article citation only
Format	EndNote, Zotero or Papers Reference Manager Refworks BibTeX

BMC Cancer

Viewing options

Associated material

Tools

Share this article

Download references

Doxorubicin-enriched, ALDH^br mouse breast cancer stem cells are treatable to oncolytic herpes simplex virus type 1

BMC Cancer

Viewing options

Associated material

Related literature

Cited by

Other articles by authors

Related articles/pages

Tools

Share this article

Download references

Doxorubicin-enriched, ALDHbr mouse breast cancer stem cells are treatable to oncolytic herpes simplex virus type 1

Doxorubicin-enriched, ALDH^br mouse breast cancer stem cells are treatable to oncolytic herpes simplex virus type 1